Anaveon
Anaveon are developing IL-2 complexes which selectively promote effector T cell functions. Our compounds act as effective immune adjuvants with a broad therapeutic window and marked preclinical efficacy against cancer either as monotherapy or in combination with other therapies.
Tech Stack (9 technologies)
Frequently Asked Questions
What technologies does Anaveon use?+
Anaveon uses 9 technologies including AOS, Google Analytics, Google Tag Manager.
What industry is Anaveon in?+
Anaveon operates in the Therapeutics industry.
Where is Anaveon based?+
Anaveon is headquartered in Switzerland.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026